Zenith Minerals Limited

ZNC

Zenith Minerals Ltd. is engaged in the identification, exploration and development of base, industrial and precious metal deposits. The company is headquartered in Perth, Western Australia. The company went IPO on 2007-05-29. The firm is focused on minerals containing lithium and related metals required for rechargeable lithium-ion batteries for electric vehicles and renewable energy storage. The company also has a portfolio of gold and base metal deposits located in Western Australia and Queensland. Its projects are Split Rocks Lithium-Tantalum Project, Waratah Well Lithium-Tantalum Project, Hayes Hill Lithium - Nickel Project, Split Rocks Gold Project, Red Mountain Gold-Silver Project and Earaheedy Zinc Project. The Split Rocks Project is located approximately 40 km south of the regional town of Marvel Loch in the Goldfields Region of Western Australia. The Waratah Well project is located over 20 km northwest of the regional town of Yalgoo in the Murchison Region of Western Australia. The Hayes Hill project consists of four granted exploration licenses in a highly mineral prospective corridor north of Norseman in Western Australia.

Zoono Group Limited

ZNO

Zoono Group Ltd. is a pharmaceutical and biotechnology company. The company is headquartered in Sydney, New South Wales. The firm produces sprays, wipes and foams suited for skin care, surface sanitizers and mold remediation treatments. Its products are based on the ZOONO molecule, an antimicrobial molecule that bonds to any surface and kills pathogens including bacteria, viruses, algae, fungi and mold. The firm markets its products in various countries, including Australasia, Asia, United States, India, United Kingdom and Europe. Its subsidiaries include Zoono Group Limited (NZ), Zoono Limited, Zoono Holdings Limited (UK), Zoono EU Limited, Zoono (Shanghai) Biotech Co. Limited, Zoono Holdings USA LLC and Zoono South Africa (Pty) Ltd.

Zelira Therapeutics Limited

ZLD

Zelira Therapeutics Ltd. is a bio-pharmaceutical company. The company is headquartered in Perth, Western Australia. The company went IPO on 2003-07-28. The firm is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. The company owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. The company is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. The company has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The firm in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.

Zinc of Ireland NL

ZMI

Zinc of Ireland NL engages in the mineral exploration and project evaluation. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-09-18. Its 100%-owned Kildare Project is located approximately 40 kilometers (km) southwest of Dublin and comprises approximately 240 square kilometers (km2) of contiguous prospecting licenses. The Earaheedy license is located approximately 200 km east of Wiluna and 220 km southeast of the RTR Chinook and Magazine Pb-Zn discoveries. The Earaheedy license contains approximately 23 km of strike of the target unconformity between the Frere and Yelma formations. The firm also covers approximately 1380 km2 lithium exploration project in the Superior Province, Manitoba, Canada. Through its subsidiary Avignon Resources Pty Ltd, it has six mineral exploration licenses and seven mining claims in Manitoba.